Nadia Assenova

Nadia Assenova is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical industry, currently serving as VP of Regulatory Affairs, International at Moderna since February 2021. Nadia has previously held leadership roles including VP of Regulatory Affairs at Arvelle Therapeutics, Head of Regulatory Affairs for Europe at Sage Therapeutics, and Sr. Director of Regulatory Affairs for EMEA at Alexion Pharmaceuticals. Additional positions include Director Regulatory Affairs at Cubist Pharmaceuticals and Global Program Regulatory Director at Novartis, encompassing various strategic responsibilities in regulatory strategy, submissions, and compliance across multiple regions. Nadia holds a Doctor's Degree in Business Administration and Management from SDA Bocconi, along with advanced degrees in International Business Law, Health Policy, General Management, and Pharmacy from prestigious institutions.